Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes

  • G. Perrone | g.perrone@unicampus.it Universita' Campus Bio-Medico di Roma, Italy.
  • S. Morini
  • D. Santini
  • C. Rabitti
  • B. Vincenzi
  • R. Alloni
  • A. Antinori
  • P. Magistrelli
  • R. Lai
  • C. Cass
  • J. R. Mackey
  • R. Coppola
  • G. Tonini
  • A. Onetti Muda

Abstract

The human equilibrative nucleoside transporter 1 (hENT1) is the major means by which gemcitabine enters human cells; recent evidence exists that hENT1 is expressed in carcinoma of the ampulla of Vater and that it should be considered as a molecular prognostic marker for patients with resected ampullary cancer. Aim of the present study is to evaluate the variations of hENT1 expression in ampullary carcinomas and to correlate such variations with histological subtypes and clinicopathological parameters. Forty-one ampullary carcinomas were histologically classified into intestinal, pancreaticobiliary and unusual types. hENT1 and Ki67 expression were evaluated by immunohistochemistry, and apoptotic cells were identified by the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate biotin nick end labelling (TUNEL) method. hENT1 overexpression was detected in 63.4% ampullary carcinomas. A significant difference in terms of hENT1 and Ki67 expression was found between intestinal vs. pancreaticobiliary types (P=0.03 and P=0.009 respectively). Moreover, a significant statistical positive correlation was found between apoptotic and proliferative Index (P=0.036), while no significant correlation was found between hENT1 and apoptosis. Our results on hENT1 expression suggest that classification of ampullary carcinoma by morphological subtypes may represent an additional tool in prospective clinical trials aimed at examining treatment efficacy; in addition, data obtained from Ki67 and TUNEL suggest a key role of hENT1 in tumour growth of ampullary carcinoma.

Downloads

Download data is not yet available.

Author Biography

G. Perrone, Universita' Campus Bio-Medico di Roma
Dipartimento di Anatomia Patologica
Published
2010-09-13
Section
Original Papers
Keywords:
hENT1, Histotypes, Vater ampulla, Cancer, Immunohistochemistry
Statistics
Abstract views: 584

PDF: 179
HTML: 1545
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Perrone, G., Morini, S., Santini, D., Rabitti, C., Vincenzi, B., Alloni, R., Antinori, A., Magistrelli, P., Lai, R., Cass, C., Mackey, J. R., Coppola, R., Tonini, G., & Onetti Muda, A. (2010). Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes. European Journal of Histochemistry, 54(3), e38. https://doi.org/10.4081/ejh.2010.e38